World Journal of Diabetes - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1537)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series.

Item

Count

PDF

HTML

915

Figures (1-8)

135

Sum=1116

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

270

Sum=316

Apr 15, 2024 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Zhang GL, Liu Y, Liu YF, Huang XT, Tao Y, Chen ZH, Lai HL. Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome. World J Diabetes 2024; 15(4): 724-734 [PMID: 38680706 DOI: 10.4239/wjd.v15.i4.724]
URL:	https://www.wjgnet.com/1948-9358/full/v15/i4/724.htm

Number	Citing Articles
1	Saeed Mohammadi, Ahmed Al-Harrasi. Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy?. World Journal of Diabetes 2024; 15(9): 1847-1852 doi: 10.4239/wjd.v15.i9.1847 Abstract(179) \| Core Tip(159) \| Full Article(HTML)(710) \| Full Article with Cover (PDF)-1354K(32) \| Full Article (Word)-249K(2) \| Audio-895K(1) \| Peer-Review Report-170K(13) \| Answering Reviewers-54K(23) \| Full Article (PDF)-986K(53) \| Full Article (XML)-69K(14) \| Times Cited (0) \| Total Visits (1546) \| Open
2	Chun-Yao Cheng, Wen-Rui Hao, Ju-Chi Liu, Tzu-Hurng Cheng. Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies. World Journal of Diabetes 2024; 15(12): 2370-2375 doi: 10.4239/wjd.v15.i12.2370 Abstract(36) \| Core Tip(32) \| Full Article(HTML)(129) \| Full Article with Cover (PDF)-578K(10) \| Audio-218K(2) \| Peer-Review Report-220K(5) \| Answering Reviewers-95K(5) \| Full Article (PDF)-386K(9) \| Full Article (XML)-53K(5) \| Times Cited (0) \| Total Visits (292) \| Open
3	Jing Guo, Yi Cao, Qing-Yuan Wu, Lu-Sha Cen. Potential mechanism of teneligliptin in the treatment of diabetic cardiomyopathy. World Journal of Diabetes 2024; 15(10): 2002-2005 doi: 10.4239/wjd.v15.i10.2002 Abstract(122) \| Core Tip(116) \| Full Article(HTML)(941) \| Full Article with Cover (PDF)-724K(25) \| Audio-707K(3) \| Peer-Review Report-172K(19) \| Answering Reviewers-75K(22) \| Full Article (PDF)-352K(43) \| Full Article (XML)-40K(25) \| Times Cited (0) \| Total Visits (1525) \| Open
4	Cornelius James Fernandez, Sahana Shetty, Joseph M Pappachan. Diabetic cardiomyopathy: Emerging therapeutic options. World Journal of Diabetes 2024; 15(8): 1677-1682 doi: 10.4239/wjd.v15.i8.1677 Abstract(205) \| Core Tip(198) \| Full Article(HTML)(2048) \| Full Article with Cover (PDF)-895K(38) \| Audio-1389K(6) \| Peer-Review Report-310K(24) \| Answering Reviewers-52K(34) \| Full Article (PDF)-537K(75) \| Full Article (XML)-50K(28) \| Times Cited (1) \| Total Visits (3011) \| Open
5	Ashraf Al Madhoun. Teneligliptin: A potential therapeutic approach for diabetic cardiomyopathy. World Journal of Diabetes 2024; 15(8): 1654-1658 doi: 10.4239/wjd.v15.i8.1654 Abstract(225) \| Core Tip(227) \| Full Article(HTML)(1747) \| Full Article with Cover (PDF)-719K(36) \| Audio-1438K(9) \| Peer-Review Report-196K(21) \| Answering Reviewers-62K(33) \| Full Article (PDF)-363K(78) \| Full Article (XML)-47K(21) \| Times Cited (0) \| Total Visits (2686) \| Open
6	Lu Cai, Yi Tan, Md Shahidul Islam, Michael Horowitz, Kupper A Wintergerst. Diabetic cardiomyopathy: Importance of direct evidence to support the roles of NOD-like receptor protein 3 inflammasome and pyroptosis. World Journal of Diabetes 2024; 15(8): 1659-1662 doi: 10.4239/wjd.v15.i8.1659 Abstract(171) \| Core Tip(190) \| Full Article(HTML)(1711) \| Full Article with Cover (PDF)-716K(36) \| Audio-1342K(8) \| Peer-Review Report-311K(18) \| Answering Reviewers-142K(31) \| Full Article (PDF)-359K(73) \| Full Article (XML)-57K(24) \| Times Cited (0) \| Total Visits (2466) \| Open

Number	Citing Articles
1	Saeed Mohammadi, Ahmed Al-Harrasi. Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy?. World Journal of Diabetes 2024; 15(9): 1847-1852 doi: 10.4239/wjd.v15.i9.1847 Abstract(179) \| Core Tip(159) \| Full Article(HTML)(710) \| Full Article with Cover (PDF)-1354K(32) \| Full Article (Word)-249K(2) \| Audio-895K(1) \| Peer-Review Report-170K(13) \| Answering Reviewers-54K(23) \| Full Article (PDF)-986K(53) \| Full Article (XML)-69K(14) \| Times Cited (0) \| Total Visits (1546) \| Open
2	Chun-Yao Cheng, Wen-Rui Hao, Ju-Chi Liu, Tzu-Hurng Cheng. Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies. World Journal of Diabetes 2024; 15(12): 2370-2375 doi: 10.4239/wjd.v15.i12.2370 Abstract(36) \| Core Tip(32) \| Full Article(HTML)(129) \| Full Article with Cover (PDF)-578K(10) \| Audio-218K(2) \| Peer-Review Report-220K(5) \| Answering Reviewers-95K(5) \| Full Article (PDF)-386K(9) \| Full Article (XML)-53K(5) \| Times Cited (0) \| Total Visits (292) \| Open
3	Jing Guo, Yi Cao, Qing-Yuan Wu, Lu-Sha Cen. Potential mechanism of teneligliptin in the treatment of diabetic cardiomyopathy. World Journal of Diabetes 2024; 15(10): 2002-2005 doi: 10.4239/wjd.v15.i10.2002 Abstract(122) \| Core Tip(116) \| Full Article(HTML)(941) \| Full Article with Cover (PDF)-724K(25) \| Audio-707K(3) \| Peer-Review Report-172K(19) \| Answering Reviewers-75K(22) \| Full Article (PDF)-352K(43) \| Full Article (XML)-40K(25) \| Times Cited (0) \| Total Visits (1525) \| Open
4	Cornelius James Fernandez, Sahana Shetty, Joseph M Pappachan. Diabetic cardiomyopathy: Emerging therapeutic options. World Journal of Diabetes 2024; 15(8): 1677-1682 doi: 10.4239/wjd.v15.i8.1677 Abstract(205) \| Core Tip(198) \| Full Article(HTML)(2048) \| Full Article with Cover (PDF)-895K(38) \| Audio-1389K(6) \| Peer-Review Report-310K(24) \| Answering Reviewers-52K(34) \| Full Article (PDF)-537K(75) \| Full Article (XML)-50K(28) \| Times Cited (1) \| Total Visits (3011) \| Open
5	Ashraf Al Madhoun. Teneligliptin: A potential therapeutic approach for diabetic cardiomyopathy. World Journal of Diabetes 2024; 15(8): 1654-1658 doi: 10.4239/wjd.v15.i8.1654 Abstract(225) \| Core Tip(227) \| Full Article(HTML)(1747) \| Full Article with Cover (PDF)-719K(36) \| Audio-1438K(9) \| Peer-Review Report-196K(21) \| Answering Reviewers-62K(33) \| Full Article (PDF)-363K(78) \| Full Article (XML)-47K(21) \| Times Cited (0) \| Total Visits (2686) \| Open
6	Lu Cai, Yi Tan, Md Shahidul Islam, Michael Horowitz, Kupper A Wintergerst. Diabetic cardiomyopathy: Importance of direct evidence to support the roles of NOD-like receptor protein 3 inflammasome and pyroptosis. World Journal of Diabetes 2024; 15(8): 1659-1662 doi: 10.4239/wjd.v15.i8.1659 Abstract(171) \| Core Tip(190) \| Full Article(HTML)(1711) \| Full Article with Cover (PDF)-716K(36) \| Audio-1342K(8) \| Peer-Review Report-311K(18) \| Answering Reviewers-142K(31) \| Full Article (PDF)-359K(73) \| Full Article (XML)-57K(24) \| Times Cited (0) \| Total Visits (2466) \| Open